Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Price/FCF Ratio: 17.42

popular:market cap|pe ratio|revenue|price history|total return

Is the Price/FCF ratio high or low?

The Price/FCF ratio of 17.42 is 14% above its 5-year average of 15.26, around the middle of its 5-year range (8.10–27.18).

7.94% above its 12-month average of 16.14.

P/E Ratio|FCF Growth|Operating Margin|All Metrics
DGX Price/FCF Ratio

DGX Price/FCF Ratio Chart

17.42
-8.89% 1Y
DGX Price/FCF Ratio

DGX Average Price/FCF Ratio Chart

DGX Price/FCF Ratio

DGX Current vs Average Price/FCF Ratio Chart

DGX Price/FCF Ratio Metrics

PRICE/FCF RATIO

17.42

PRICE/FCF RATIO AVG TTM

16.14

PRICE/FCF RATIO AVG 3Y

17.30

PRICE/FCF RATIO AVG 5Y

15.26

PRICE/FCF RATIO AVG 10Y

15.42

PRICE/FCF RATIO AVG 15Y

15.13

PRICE/FCF RATIO AVG 20Y

14.49

CURRENT VS TTM AVG

+7.94%

CURRENT VS 3Y AVG

+0.67%

CURRENT VS 5Y AVG

+14.17%

CURRENT VS 10Y AVG

+13.00%

CURRENT VS 15Y AVG

+15.13%

CURRENT VS 20Y AVG

+20.20%

DGX Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B17.4216.1417.3015.26
BioNTech SE (BNTX)vs ›$22.76B15.2233.4811.0914.34
United Therapeutics Corporation (UTHR)vs ›$23.07B25.2220.4818.0617.73
Moderna, Inc. (MRNA)vs ›$23.71BN/A28.0727.2327.23
Labcorp Holdings Inc. (LH)vs ›$21.83B15.9517.3119.6315.89
Incyte Corporation (INCY)vs ›$21.48B15.3319.03108.1874.05
Waters Corporation (WAT)vs ›$24.57B117.2643.2540.4039.05
Mettler-Toledo International Inc. (MTD)vs ›$25.13B31.7831.3131.0335.88
STERIS plc (STE)vs ›$20.52B21.3125.7933.6940.39
Veeva Systems Inc. (VEEV)vs ›$25.68B15.9629.1033.4738.92

Free Cash Flow Valuation

P/FCF Ratio

17.4

FCF Yield

5.74%

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio FAQ

What is the Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The Price/FCF ratio for DGX stock is 17.42.
Is Quest Diagnostics Incorporated's Price/FCF ratio high or low?
The Price/FCF ratio of 17.42 is 14% above its 5-year average of 15.26, around the middle of its 5-year range (8.10–27.18).
What is the TTM average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average Price/FCF ratio for DGX stock is 16.14.
What is the 3Y average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average Price/FCF ratio for DGX stock is 17.30.
What is the 5Y average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average Price/FCF ratio for DGX stock is 15.26.
What is the 10Y average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average Price/FCF ratio for DGX stock is 15.42.
What is the 15Y average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average Price/FCF ratio for DGX stock is 15.13.
What is the 20Y average Price/FCF ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average Price/FCF ratio for DGX stock is 14.49.

DGX Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-2517.42
2026-06-2417.16
2026-06-2316.65
2026-06-2216.35
2026-06-1816.47
2026-06-1716.70
2026-06-1616.98
2026-06-1517.08
2026-06-1217.15
2026-06-1117.22
2026-06-1017.21
2026-06-0917.28
2026-06-0816.66
2026-06-0516.92
2026-06-0416.57
2026-06-0316.36
2026-06-0216.32
2026-06-0116.23
2026-05-2916.46
2026-05-2816.57
2026-05-2716.39
2026-05-2616.29
2026-05-2216.49
2026-05-2116.37
2026-05-2016.37
2026-05-1916.08
2026-05-1816.03
2026-05-1515.76
2026-05-1415.87
2026-05-1316.12
2026-05-1216.06
2026-05-1116.03
2026-05-0815.83
2026-05-0716.12
2026-05-0615.97
2026-05-0516.12
2026-05-0416.17
2026-05-0116.27
2026-04-3016.40
2026-04-2915.99
2026-04-2816.47
2026-04-2716.61
2026-04-2416.58
2026-04-2316.85
2026-04-2217.23
2026-04-2116.90
2026-04-2016.18
2026-04-1716.07
2026-04-1615.78
2026-04-1515.78
2026-04-1416.00
2026-04-1315.90
2026-04-1015.78
2026-04-0916.30
2026-04-0816.38
2026-04-0716.22
2026-04-0616.40
2026-04-0216.32
2026-04-0116.29
2026-03-3116.15
2026-03-3016.25
2026-03-2716.11
2026-03-2616.33
2026-03-2516.19
2026-03-2416.16
2026-03-2316.12
2026-03-2016.09
2026-03-1916.00
2026-03-1816.09
2026-03-1716.37
2026-03-1616.40
2026-03-1316.46
2026-03-1216.56
2026-03-1116.53
2026-03-1016.56
2026-03-0916.61
2026-03-0616.42
2026-03-0516.81
2026-03-0417.18
2026-03-0317.17
2026-03-0217.33
2026-02-2717.46
2026-02-2617.40
2026-02-2516.86
2026-02-2417.00
2026-02-2316.83
2026-02-2016.42
2026-02-1916.42
2026-02-1816.58
2026-02-1716.67
2026-02-1316.78
2026-02-1216.78
2026-02-1116.98
2026-02-1016.66
2026-02-0915.51
2026-02-0615.47
2026-02-0515.60
2026-02-0415.35
2026-02-0315.02
2026-02-0215.01
2026-01-3015.17
2026-01-2914.79
2026-01-2814.82
2026-01-2714.95
2026-01-2614.81
2026-01-2314.68
2026-01-2214.78
2026-01-2114.98
2026-01-2015.33
2026-01-1615.37
2026-01-1515.43
2026-01-1415.15
2026-01-1314.60
2026-01-1214.27
2026-01-0914.15
2026-01-0814.42
2026-01-0714.45
2026-01-0614.64
2026-01-0514.07
2026-01-0214.10
2025-12-3114.08
2025-12-3014.24
2025-12-2914.24
2025-12-2614.27
2025-12-2414.27
2025-12-2314.20
2025-12-2214.30
2025-12-1914.28
2025-12-1814.29
2025-12-1714.53
2025-12-1614.49
2025-12-1514.93
2025-12-1214.81
2025-12-1114.73
2025-12-1014.56
2025-12-0914.57
2025-12-0814.75
2025-12-0514.81
2025-12-0414.94
2025-12-0314.81
2025-12-0214.81
2025-12-0114.91
2025-11-2815.35
2025-11-2615.39
2025-11-2515.60
2025-11-2415.46
2025-11-2115.51
2025-11-2015.22
2025-11-1915.09
2025-11-1815.03
2025-11-1715.10
2025-11-1415.17
2025-11-1315.22
2025-11-1215.16
2025-11-1115.32
2025-11-1014.95
2025-11-0714.56
2025-11-0614.32
2025-11-0514.46
2025-11-0414.44
2025-11-0314.51
2025-10-3114.27
2025-10-3014.26
2025-10-2914.18
2025-10-2814.46
2025-10-2714.62
2025-10-2414.78
2025-10-2314.86
2025-10-2214.70
2025-10-2114.98
2025-10-2017.58
2025-10-1717.50
2025-10-1617.25
2025-10-1517.30
2025-10-1417.12
2025-10-1316.87
2025-10-1016.99
2025-10-0916.75
2025-10-0816.70
2025-10-0716.79
2025-10-0616.47
2025-10-0316.56
2025-10-0216.71
2025-10-0116.81
2025-09-3017.59
2025-09-2917.43
2025-09-2617.45
2025-09-2517.12
2025-09-2417.25
2025-09-2317.26
2025-09-2217.05
2025-09-1916.95
2025-09-1816.93
2025-09-1716.83
2025-09-1616.63
2025-09-1516.67
2025-09-1216.89
2025-09-1116.94
2025-09-1016.63
2025-09-0916.87
2025-09-0816.85
2025-09-0516.94
2025-09-0416.63
2025-09-0316.57
2025-09-0216.50
2025-08-2916.77
2025-08-2816.54
2025-08-2716.60
2025-08-2616.65
2025-08-2516.49
2025-08-2216.64
2025-08-2116.96
2025-08-2017.02
2025-08-1916.88
2025-08-1816.52
2025-08-1516.60
2025-08-1416.47
2025-08-1316.53
2025-08-1216.50
2025-08-1116.47
2025-08-0816.34
2025-08-0716.09
2025-08-0615.97
2025-08-0516.00
2025-08-0415.92
2025-08-0115.77
2025-07-3115.46
2025-07-3015.58
2025-07-2915.50
2025-07-2815.50
2025-07-2515.56
2025-07-2415.87
2025-07-2315.74
2025-07-2219.07
2025-07-2117.81
2025-07-1817.86
2025-07-1718.00
2025-07-1617.87
2025-07-1517.81
2025-07-1418.02
2025-07-1117.99
2025-07-1018.35
2025-07-0918.58
2025-07-0818.46
2025-07-0718.62
2025-07-0318.93
2025-07-0218.90
2025-07-0119.19
2025-06-3019.22
2025-06-2719.03
2025-06-2618.95
2025-06-2519.12
2025-06-2419.25
2025-06-2319.23
2025-06-2019.20
2025-06-1819.24
2025-06-1719.15
2025-06-1619.48
2025-06-1319.28
2025-06-1219.16

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

P/E RatioFCF GrowthOperating MarginAll Metrics

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials